Toxoid Vaccines Market, Global Outlook and Forecast 2022-2028
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
This report contains market size and forecasts of Toxoid Vaccines in global, including the following market information:
Global Toxoid Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Toxoid Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Toxoid Vaccines companies in 2021 (%)
The global Toxoid Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Tetanus Toxoid (TT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Toxoid Vaccines include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, Bharat Biotech, Shenzhen Kangtai Biological Products, Bausch Health and Emergent Biosolutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Toxoid Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Toxoid Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Toxoid Vaccines Market Segment Percentages, by Type, 2021 (%)
Global Toxoid Vaccines Market Segment Percentages, by Application, 2021 (%)
Global Toxoid Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Toxoid Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Toxoid Vaccines revenues share in global market, 2021 (%)
Key companies Toxoid Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Toxoid Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
This report contains market size and forecasts of Toxoid Vaccines in global, including the following market information:
Global Toxoid Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Toxoid Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Toxoid Vaccines companies in 2021 (%)
The global Toxoid Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Tetanus Toxoid (TT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Toxoid Vaccines include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, Bharat Biotech, Shenzhen Kangtai Biological Products, Bausch Health and Emergent Biosolutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Toxoid Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Toxoid Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Toxoid Vaccines Market Segment Percentages, by Type, 2021 (%)
- Monovalent Tetanus Toxoid (TT)
- Diphtheria
- Tetanus
- Pertussis (DTaP)
- Diphtheria and Tetanus (DT)
Global Toxoid Vaccines Market Segment Percentages, by Application, 2021 (%)
- Hospitals And Clinics
- Government Organizations
- Research
- Others
Global Toxoid Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Toxoid Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Toxoid Vaccines revenues share in global market, 2021 (%)
Key companies Toxoid Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Toxoid Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi Pasteur
- AstraZeneca
- Bharat Biotech
- Shenzhen Kangtai Biological Products
- Bausch Health
- Emergent Biosolutions
- Astellas Pharma
- Panacea Biotec
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Toxoid Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Toxoid Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL TOXOID VACCINES OVERALL MARKET SIZE
2.1 Global Toxoid Vaccines Market Size: 2021 VS 2028
2.2 Global Toxoid Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Toxoid Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Toxoid Vaccines Players in Global Market
3.2 Top Global Toxoid Vaccines Companies Ranked by Revenue
3.3 Global Toxoid Vaccines Revenue by Companies
3.4 Global Toxoid Vaccines Sales by Companies
3.5 Global Toxoid Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Toxoid Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Toxoid Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Toxoid Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Toxoid Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Toxoid Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Toxoid Vaccines Market Size Markets, 2021 & 2028
4.1.2 Monovalent Tetanus Toxoid (TT)
4.1.3 Diphtheria
4.1.4 Tetanus
4.1.5 Pertussis (DTaP)
4.1.6 Diphtheria and Tetanus (DT)
4.2 By Type - Global Toxoid Vaccines Revenue & Forecasts
4.2.1 By Type - Global Toxoid Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Toxoid Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Toxoid Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Toxoid Vaccines Sales & Forecasts
4.3.1 By Type - Global Toxoid Vaccines Sales, 2017-2022
4.3.2 By Type - Global Toxoid Vaccines Sales, 2023-2028
4.3.3 By Type - Global Toxoid Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Toxoid Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Toxoid Vaccines Market Size, 2021 & 2028
5.1.2 Hospitals And Clinics
5.1.3 Government Organizations
5.1.4 Research
5.1.5 Others
5.2 By Application - Global Toxoid Vaccines Revenue & Forecasts
5.2.1 By Application - Global Toxoid Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Toxoid Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Toxoid Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Toxoid Vaccines Sales & Forecasts
5.3.1 By Application - Global Toxoid Vaccines Sales, 2017-2022
5.3.2 By Application - Global Toxoid Vaccines Sales, 2023-2028
5.3.3 By Application - Global Toxoid Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Toxoid Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Toxoid Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Toxoid Vaccines Revenue & Forecasts
6.2.1 By Region - Global Toxoid Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Toxoid Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Toxoid Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Toxoid Vaccines Sales & Forecasts
6.3.1 By Region - Global Toxoid Vaccines Sales, 2017-2022
6.3.2 By Region - Global Toxoid Vaccines Sales, 2023-2028
6.3.3 By Region - Global Toxoid Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Toxoid Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Toxoid Vaccines Sales, 2017-2028
6.4.3 US Toxoid Vaccines Market Size, 2017-2028
6.4.4 Canada Toxoid Vaccines Market Size, 2017-2028
6.4.5 Mexico Toxoid Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Toxoid Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Toxoid Vaccines Sales, 2017-2028
6.5.3 Germany Toxoid Vaccines Market Size, 2017-2028
6.5.4 France Toxoid Vaccines Market Size, 2017-2028
6.5.5 U.K. Toxoid Vaccines Market Size, 2017-2028
6.5.6 Italy Toxoid Vaccines Market Size, 2017-2028
6.5.7 Russia Toxoid Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Toxoid Vaccines Market Size, 2017-2028
6.5.9 Benelux Toxoid Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Toxoid Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Toxoid Vaccines Sales, 2017-2028
6.6.3 China Toxoid Vaccines Market Size, 2017-2028
6.6.4 Japan Toxoid Vaccines Market Size, 2017-2028
6.6.5 South Korea Toxoid Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Toxoid Vaccines Market Size, 2017-2028
6.6.7 India Toxoid Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Toxoid Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Toxoid Vaccines Sales, 2017-2028
6.7.3 Brazil Toxoid Vaccines Market Size, 2017-2028
6.7.4 Argentina Toxoid Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Toxoid Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Toxoid Vaccines Sales, 2017-2028
6.8.3 Turkey Toxoid Vaccines Market Size, 2017-2028
6.8.4 Israel Toxoid Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Toxoid Vaccines Market Size, 2017-2028
6.8.6 UAE Toxoid Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Toxoid Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Toxoid Vaccines Major Product Offerings
7.2.4 Merck Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Toxoid Vaccines Major Product Offerings
7.3.4 Pfizer Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Corporate Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Toxoid Vaccines Major Product Offerings
7.4.4 Sanofi Pasteur Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Pasteur Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Toxoid Vaccines Major Product Offerings
7.5.4 AstraZeneca Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Bharat Biotech
7.6.1 Bharat Biotech Corporate Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Toxoid Vaccines Major Product Offerings
7.6.4 Bharat Biotech Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Bharat Biotech Key News
7.7 Shenzhen Kangtai Biological Products
7.7.1 Shenzhen Kangtai Biological Products Corporate Summary
7.7.2 Shenzhen Kangtai Biological Products Business Overview
7.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Major Product Offerings
7.7.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Shenzhen Kangtai Biological Products Key News
7.8 Bausch Health
7.8.1 Bausch Health Corporate Summary
7.8.2 Bausch Health Business Overview
7.8.3 Bausch Health Toxoid Vaccines Major Product Offerings
7.8.4 Bausch Health Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Bausch Health Key News
7.9 Emergent Biosolutions
7.9.1 Emergent Biosolutions Corporate Summary
7.9.2 Emergent Biosolutions Business Overview
7.9.3 Emergent Biosolutions Toxoid Vaccines Major Product Offerings
7.9.4 Emergent Biosolutions Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Emergent Biosolutions Key News
7.10 Astellas Pharma
7.10.1 Astellas Pharma Corporate Summary
7.10.2 Astellas Pharma Business Overview
7.10.3 Astellas Pharma Toxoid Vaccines Major Product Offerings
7.10.4 Astellas Pharma Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Astellas Pharma Key News
7.11 Panacea Biotec
7.11.1 Panacea Biotec Corporate Summary
7.11.2 Panacea Biotec Toxoid Vaccines Business Overview
7.11.3 Panacea Biotec Toxoid Vaccines Major Product Offerings
7.11.4 Panacea Biotec Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Panacea Biotec Key News
8 GLOBAL TOXOID VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Toxoid Vaccines Production Capacity, 2017-2028
8.2 Toxoid Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Toxoid Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 TOXOID VACCINES SUPPLY CHAIN ANALYSIS
10.1 Toxoid Vaccines Industry Value Chain
10.2 Toxoid Vaccines Upstream Market
10.3 Toxoid Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Toxoid Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Toxoid Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Toxoid Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL TOXOID VACCINES OVERALL MARKET SIZE
2.1 Global Toxoid Vaccines Market Size: 2021 VS 2028
2.2 Global Toxoid Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Toxoid Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Toxoid Vaccines Players in Global Market
3.2 Top Global Toxoid Vaccines Companies Ranked by Revenue
3.3 Global Toxoid Vaccines Revenue by Companies
3.4 Global Toxoid Vaccines Sales by Companies
3.5 Global Toxoid Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Toxoid Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Toxoid Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Toxoid Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Toxoid Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Toxoid Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Toxoid Vaccines Market Size Markets, 2021 & 2028
4.1.2 Monovalent Tetanus Toxoid (TT)
4.1.3 Diphtheria
4.1.4 Tetanus
4.1.5 Pertussis (DTaP)
4.1.6 Diphtheria and Tetanus (DT)
4.2 By Type - Global Toxoid Vaccines Revenue & Forecasts
4.2.1 By Type - Global Toxoid Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Toxoid Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Toxoid Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Toxoid Vaccines Sales & Forecasts
4.3.1 By Type - Global Toxoid Vaccines Sales, 2017-2022
4.3.2 By Type - Global Toxoid Vaccines Sales, 2023-2028
4.3.3 By Type - Global Toxoid Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Toxoid Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Toxoid Vaccines Market Size, 2021 & 2028
5.1.2 Hospitals And Clinics
5.1.3 Government Organizations
5.1.4 Research
5.1.5 Others
5.2 By Application - Global Toxoid Vaccines Revenue & Forecasts
5.2.1 By Application - Global Toxoid Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Toxoid Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Toxoid Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Toxoid Vaccines Sales & Forecasts
5.3.1 By Application - Global Toxoid Vaccines Sales, 2017-2022
5.3.2 By Application - Global Toxoid Vaccines Sales, 2023-2028
5.3.3 By Application - Global Toxoid Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Toxoid Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Toxoid Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Toxoid Vaccines Revenue & Forecasts
6.2.1 By Region - Global Toxoid Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Toxoid Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Toxoid Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Toxoid Vaccines Sales & Forecasts
6.3.1 By Region - Global Toxoid Vaccines Sales, 2017-2022
6.3.2 By Region - Global Toxoid Vaccines Sales, 2023-2028
6.3.3 By Region - Global Toxoid Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Toxoid Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Toxoid Vaccines Sales, 2017-2028
6.4.3 US Toxoid Vaccines Market Size, 2017-2028
6.4.4 Canada Toxoid Vaccines Market Size, 2017-2028
6.4.5 Mexico Toxoid Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Toxoid Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Toxoid Vaccines Sales, 2017-2028
6.5.3 Germany Toxoid Vaccines Market Size, 2017-2028
6.5.4 France Toxoid Vaccines Market Size, 2017-2028
6.5.5 U.K. Toxoid Vaccines Market Size, 2017-2028
6.5.6 Italy Toxoid Vaccines Market Size, 2017-2028
6.5.7 Russia Toxoid Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Toxoid Vaccines Market Size, 2017-2028
6.5.9 Benelux Toxoid Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Toxoid Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Toxoid Vaccines Sales, 2017-2028
6.6.3 China Toxoid Vaccines Market Size, 2017-2028
6.6.4 Japan Toxoid Vaccines Market Size, 2017-2028
6.6.5 South Korea Toxoid Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Toxoid Vaccines Market Size, 2017-2028
6.6.7 India Toxoid Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Toxoid Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Toxoid Vaccines Sales, 2017-2028
6.7.3 Brazil Toxoid Vaccines Market Size, 2017-2028
6.7.4 Argentina Toxoid Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Toxoid Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Toxoid Vaccines Sales, 2017-2028
6.8.3 Turkey Toxoid Vaccines Market Size, 2017-2028
6.8.4 Israel Toxoid Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Toxoid Vaccines Market Size, 2017-2028
6.8.6 UAE Toxoid Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Toxoid Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Toxoid Vaccines Major Product Offerings
7.2.4 Merck Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Toxoid Vaccines Major Product Offerings
7.3.4 Pfizer Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Corporate Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Toxoid Vaccines Major Product Offerings
7.4.4 Sanofi Pasteur Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Pasteur Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Toxoid Vaccines Major Product Offerings
7.5.4 AstraZeneca Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Bharat Biotech
7.6.1 Bharat Biotech Corporate Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Toxoid Vaccines Major Product Offerings
7.6.4 Bharat Biotech Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Bharat Biotech Key News
7.7 Shenzhen Kangtai Biological Products
7.7.1 Shenzhen Kangtai Biological Products Corporate Summary
7.7.2 Shenzhen Kangtai Biological Products Business Overview
7.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Major Product Offerings
7.7.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Shenzhen Kangtai Biological Products Key News
7.8 Bausch Health
7.8.1 Bausch Health Corporate Summary
7.8.2 Bausch Health Business Overview
7.8.3 Bausch Health Toxoid Vaccines Major Product Offerings
7.8.4 Bausch Health Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Bausch Health Key News
7.9 Emergent Biosolutions
7.9.1 Emergent Biosolutions Corporate Summary
7.9.2 Emergent Biosolutions Business Overview
7.9.3 Emergent Biosolutions Toxoid Vaccines Major Product Offerings
7.9.4 Emergent Biosolutions Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Emergent Biosolutions Key News
7.10 Astellas Pharma
7.10.1 Astellas Pharma Corporate Summary
7.10.2 Astellas Pharma Business Overview
7.10.3 Astellas Pharma Toxoid Vaccines Major Product Offerings
7.10.4 Astellas Pharma Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Astellas Pharma Key News
7.11 Panacea Biotec
7.11.1 Panacea Biotec Corporate Summary
7.11.2 Panacea Biotec Toxoid Vaccines Business Overview
7.11.3 Panacea Biotec Toxoid Vaccines Major Product Offerings
7.11.4 Panacea Biotec Toxoid Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Panacea Biotec Key News
8 GLOBAL TOXOID VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Toxoid Vaccines Production Capacity, 2017-2028
8.2 Toxoid Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Toxoid Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 TOXOID VACCINES SUPPLY CHAIN ANALYSIS
10.1 Toxoid Vaccines Industry Value Chain
10.2 Toxoid Vaccines Upstream Market
10.3 Toxoid Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Toxoid Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Toxoid Vaccines in Global Market
Table 2. Top Toxoid Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Toxoid Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Toxoid Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Toxoid Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Toxoid Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Toxoid Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Toxoid Vaccines Product Type
Table 9. List of Global Tier 1 Toxoid Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Toxoid Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Toxoid Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Toxoid Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Toxoid Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Toxoid Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Toxoid Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Toxoid Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Toxoid Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Toxoid Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Toxoid Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Toxoid Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Toxoid Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Toxoid Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Toxoid Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Toxoid Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Toxoid Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Toxoid Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Toxoid Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Toxoid Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Toxoid Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Toxoid Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Toxoid Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Toxoid Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Toxoid Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Toxoid Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Toxoid Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Toxoid Vaccines Product Offerings
Table 48. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Toxoid Vaccines Product Offerings
Table 51. Merck Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Toxoid Vaccines Product Offerings
Table 54. Pfizer Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi Pasteur Corporate Summary
Table 56. Sanofi Pasteur Toxoid Vaccines Product Offerings
Table 57. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Toxoid Vaccines Product Offerings
Table 60. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Bharat Biotech Corporate Summary
Table 62. Bharat Biotech Toxoid Vaccines Product Offerings
Table 63. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Shenzhen Kangtai Biological Products Corporate Summary
Table 65. Shenzhen Kangtai Biological Products Toxoid Vaccines Product Offerings
Table 66. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bausch Health Corporate Summary
Table 68. Bausch Health Toxoid Vaccines Product Offerings
Table 69. Bausch Health Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Emergent Biosolutions Corporate Summary
Table 71. Emergent Biosolutions Toxoid Vaccines Product Offerings
Table 72. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Astellas Pharma Corporate Summary
Table 74. Astellas Pharma Toxoid Vaccines Product Offerings
Table 75. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Panacea Biotec Corporate Summary
Table 77. Panacea Biotec Toxoid Vaccines Product Offerings
Table 78. Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Toxoid Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Toxoid Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Toxoid Vaccines Production by Region, 2017-2022 (K Units)
Table 82. Global Toxoid Vaccines Production by Region, 2023-2028 (K Units)
Table 83. Toxoid Vaccines Market Opportunities & Trends in Global Market
Table 84. Toxoid Vaccines Market Drivers in Global Market
Table 85. Toxoid Vaccines Market Restraints in Global Market
Table 86. Toxoid Vaccines Raw Materials
Table 87. Toxoid Vaccines Raw Materials Suppliers in Global Market
Table 88. Typical Toxoid Vaccines Downstream
Table 89. Toxoid Vaccines Downstream Clients in Global Market
Table 90. Toxoid Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of Toxoid Vaccines in Global Market
Table 2. Top Toxoid Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Toxoid Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Toxoid Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Toxoid Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Toxoid Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Toxoid Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Toxoid Vaccines Product Type
Table 9. List of Global Tier 1 Toxoid Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Toxoid Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Toxoid Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Toxoid Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Toxoid Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Toxoid Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Toxoid Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Toxoid Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Toxoid Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Toxoid Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Toxoid Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Toxoid Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Toxoid Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Toxoid Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Toxoid Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Toxoid Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Toxoid Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Toxoid Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Toxoid Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Toxoid Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Toxoid Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Toxoid Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Toxoid Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Toxoid Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Toxoid Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Toxoid Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Toxoid Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Toxoid Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Toxoid Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Toxoid Vaccines Product Offerings
Table 48. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Toxoid Vaccines Product Offerings
Table 51. Merck Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Toxoid Vaccines Product Offerings
Table 54. Pfizer Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi Pasteur Corporate Summary
Table 56. Sanofi Pasteur Toxoid Vaccines Product Offerings
Table 57. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Toxoid Vaccines Product Offerings
Table 60. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Bharat Biotech Corporate Summary
Table 62. Bharat Biotech Toxoid Vaccines Product Offerings
Table 63. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Shenzhen Kangtai Biological Products Corporate Summary
Table 65. Shenzhen Kangtai Biological Products Toxoid Vaccines Product Offerings
Table 66. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bausch Health Corporate Summary
Table 68. Bausch Health Toxoid Vaccines Product Offerings
Table 69. Bausch Health Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Emergent Biosolutions Corporate Summary
Table 71. Emergent Biosolutions Toxoid Vaccines Product Offerings
Table 72. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Astellas Pharma Corporate Summary
Table 74. Astellas Pharma Toxoid Vaccines Product Offerings
Table 75. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Panacea Biotec Corporate Summary
Table 77. Panacea Biotec Toxoid Vaccines Product Offerings
Table 78. Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Toxoid Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Toxoid Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Toxoid Vaccines Production by Region, 2017-2022 (K Units)
Table 82. Global Toxoid Vaccines Production by Region, 2023-2028 (K Units)
Table 83. Toxoid Vaccines Market Opportunities & Trends in Global Market
Table 84. Toxoid Vaccines Market Drivers in Global Market
Table 85. Toxoid Vaccines Market Restraints in Global Market
Table 86. Toxoid Vaccines Raw Materials
Table 87. Toxoid Vaccines Raw Materials Suppliers in Global Market
Table 88. Typical Toxoid Vaccines Downstream
Table 89. Toxoid Vaccines Downstream Clients in Global Market
Table 90. Toxoid Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Toxoid Vaccines Segment by Type
Figure 2. Toxoid Vaccines Segment by Application
Figure 3. Global Toxoid Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Toxoid Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Toxoid Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Toxoid Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Toxoid Vaccines Revenue in 2021
Figure 9. By Type - Global Toxoid Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Toxoid Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Toxoid Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Toxoid Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Toxoid Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Toxoid Vaccines Sales Market Share, 2017-2028
Figure 19. US Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Toxoid Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Toxoid Vaccines Sales Market Share, 2017-2028
Figure 33. China Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Toxoid Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Toxoid Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Toxoid Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Toxoid Vaccines by Region, 2021 VS 2028
Figure 50. Toxoid Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Toxoid Vaccines Segment by Type
Figure 2. Toxoid Vaccines Segment by Application
Figure 3. Global Toxoid Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Toxoid Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Toxoid Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Toxoid Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Toxoid Vaccines Revenue in 2021
Figure 9. By Type - Global Toxoid Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Toxoid Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Toxoid Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Toxoid Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Toxoid Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Toxoid Vaccines Sales Market Share, 2017-2028
Figure 19. US Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Toxoid Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Toxoid Vaccines Sales Market Share, 2017-2028
Figure 33. China Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Toxoid Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Toxoid Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Toxoid Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Toxoid Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Toxoid Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Toxoid Vaccines by Region, 2021 VS 2028
Figure 50. Toxoid Vaccines Industry Value Chain
Figure 51. Marketing Channels
